Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for millions. Dr. Celine Gounder joins to explain what this means for patients.

Medications like Ozempic only address part of food addiction. Discover the essential components of effective recovery beyond ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

Photo: Scott Olson () Getting access to popular weight loss drugs will be simpler and cheaper for some. Health insurer Cigna ...

Laurent Freixe criticises diversification efforts under previous CEO Mark Schneider as he takes Nestlé back to basics.

Procurement Magazine takes a look back at the biggest news from across the industry over the last seven days, including SAP, ...

Rising drug costs are shaking the foundation of Michigan’s health care industry, with the potential to push the market to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Explore global trends in retirement age increases and their impacts on pensions, with insights on U.S. Social Security ...